Full Text View
Tabular View
No Study Results Posted
Related Studies
Effects of Antihypertensive Drugs in Patients With Hypertension and Obstructive Sleep Apnea (OSA)
This study is ongoing, but not recruiting participants.
Study NCT01028534   Information provided by Kyoto University, Graduate School of Medicine

First Received on December 8, 2009.   Last Updated on March 25, 2013   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Obstructive Sleep Apnea
Hypertension
Additional conditions recognized in this trial
Apnea
Sleep Apnea Syndromes
Sleep Apnea, Obstructive
More general conditions related to this trial
Cardiovascular Diseases
Dyssomnias
Nervous System Diseases
Respiration Disorders
Respiratory Tract Diseases
Signs and Symptoms
Signs and Symptoms, Respiratory
Sleep Disorders
Sleep Disorders, Intrinsic
Vascular Diseases
Interventions listed in this trial
Olmesartan and Azelnidipine
Additional drug interventions recognized in this trial
Angiotensin II
Angiotensin Receptor Antagonists
Antihypertensive Agents
Calcium Channel Blockers
Olmesartan
Olmesartan medoxomil
More general drug interventions related to this trial
Angiotensin II Type 1 Receptor Blockers
Cardiovascular Agents
Membrane Transport Modulators
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Therapeutic Uses
Vasoconstrictor Agents
Sponsors listed in this trial
Kyoto University, Graduate School of Medicine


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services